Activity content starts in:
Industry Webcast
Cardiovascular Outcomes in Patients at High CV Risk: Evidence from the VESALIUS-CV StudyIndustry Webcast Sponsored by Amgen, Inc.; Not for CME/CE Credit
Join a cardiovascular expert as they explore how to reduce the risk of MACE in patients at high CV risk without a previous MI or stroke. Featuring data from the VESALIUS-CV outcomes trial alongside real-world evidence, this session highlights the urgent need for risk identification and treatment.
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 9/17/2026
Expiration Date: 9/17/2026
Topics
Faculty
Matthew J. Budoff, MD, FACC, FAHA
Professor of Medicine, David Geffen School of Medicine at UCLA, Program Director, Cardiology, Harbor-UCLA Medical Center, Torrance, CA
Learn MoreSupporters and Partners
Industry Sponsor
Amgen Inc.
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.